Concepedia

Publication | Open Access

Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial

58

Citations

22

References

2020

Year

Abstract

Administration of RSLV-132 improved severe fatigue, as determined by 4 independent patient-reported measures of fatigue, in patients with primary SS.

References

YearCitations

Page 1